Study Reference Year Region Number of patients (M/F) Age (Year) Primary disease Dialysis duration Elemental zinc dose Intervening time Comparative approach Outcomes Kobayashi et al. [15 ] Japan 70 (43/27) CKD - 34 mg/day 90/180/270/ 360 days Blank Serum zinc, hemoglobin, RBC, ESA, ERI El-Shazly et al. [16 ] Egypt 30 (29/31) CKD ≥6 months 16.5 mg/day 90 days Palcebo Serum zinc, leptin, body weight, BMI Argani et al. [17 ] Iran 60 (36/24) (50, 60) CKD - 90 mg/day 60 days Palcebo Serum zinc, albumin, BMI, body fat, body water, Ccr, hematocrit, hemoglobin, leptin, TC, TG Pakfetrat et al. [18 ] Iran 97 (55/42) CKD >3 months 50 mg/day 43 days Placebo Serum zinc, HCys, homocysteine Mazani et al. [19 ] Iran 65 (41/24) CKD >6 months 100 mg/day 60 days Placebo Serum zinc, BMI, GSH, MDA, SOD, TAC Guo and Wang [8 ] Taiwan 65 CKD >3 months 11 mg/day 56 days Blank Serum zinc, hematocrit, albumin, CD4/CD8, CRP, GFR, IL-6, MDA, nPNA, Cu, SOD, TNF-α , Vit C/E Rahimi-Ardabili et al. [20 ] Iran 60 (38/22) CKD ≥6 months 100 mg/day 60 days Placebo TC, Apo-AI, Apo-B, HDL, LDL, PON, TG Roozbeh et al. [21 ] Iran 53 (28/25) CKD ≥6 months 45 mg/day 42 days Placebo Serum zinc, HDL, LDL, TC, TG Rashidi et al. [22 ] Iran 55 (32/23) CKD ≥6 months 45 mg/day 42 days Placebo Serum zinc, CRP, hemoglobin Nava-Hernandez and Amato [23 ] 2005 Mexico 25 CKD - 100 mg/day 90 days Placebo Albumin, pre-albumin, transferrin Matson et al. [12 ] UK 15 (11/4) CKD ≥3 months 45 mg/day 42 days Placebo Serum zinc, albumin, Kt/V, calcium, CRP, nPNA, phosphate Chevalier et al. [24 ] USA 27 (22/6) CKD ≥6 months 50 mg/day 40/90 days Placebo Serum zinc, dietary intake, HDL, LDL, TC Candan et al. [25 ] Turkey 34 (18/16) 45.6 (28, 64) CKD - 20 mg/day 90 days Placebo Serum zinc, MDA, OSMO fragility Jern et al. [26 ] USA 14 56.5 (23, 80) CKD with low PCR ≥6 months 45 mg/day 40/90 days Placebo Serum zinc, dietary intake, nPNA Brodersen et al. [27 ] German 40 (22/18) 60 CKD - 60 mg/day 112 days Blank Serum zinc
Note . Sex ratio: M = male, F = female; age appears as mean, mean ± standard deviation or mean (lower limit, upper limit); -: no information was recorded in included study. Abbreivations . RBC, red blood cell; ESA, erythropoiesis-stimulating agent; ERI, ESA resistance index; BMI, body mass index; Ccr, creatinine clearance rate; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CRP, C-reactive protein; GFR, glomerular filtration rate; MDA, malondialdehyde; nPNA, normalized protein equivalent of nitrogen appearance; SOD, superoxide dismutase.